Cargando…
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
BACKGROUND: The treatment of methamphetamine dependence is a continuing global health problem. Agonist type pharmacotherapies have been used successfully to treat opioid and nicotine dependence and are being studied for the treatment of methamphetamine dependence. One potential candidate is lisdexam...
Autores principales: | Ezard, Nadine, Dunlop, Adrian, Clifford, Brendan, Bruno, Raimondo, Carr, Andrew, Bissaker, Alexandra, Lintzeris, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134059/ https://www.ncbi.nlm.nih.gov/pubmed/27905916 http://dx.doi.org/10.1186/s12888-016-1141-x |
Ejemplares similares
-
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
por: Ezard, Nadine, et al.
Publicado: (2021) -
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
por: Acheson, Liam S., et al.
Publicado: (2022) -
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018) -
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020) -
A Web-Based Therapeutic Program (We Can Do This) for Reducing Methamphetamine Use and Increasing Help-Seeking Among Aboriginal and Torres Strait Islander People: Protocol for a Randomized Wait-List Controlled Trial
por: Reilly, Rachel, et al.
Publicado: (2019)